Anthropometry (2)
- height - Subject's height (phv00426878.v1.p1)
- weight - Subject's weight (phv00426879.v1.p1)
Demographics (3)
- age - Age at enrollment (phv00426873.v1.p1)
- age_diagnosis - Age at AF diagnosis (phv00426874.v1.p1)
- sex - Gender of participant (phv00426875.v1.p1)
Disease Events (5)
- AFFECTION_STATUS - Case control status of the subject for atrial fibrillation (AF) (phv00426868.v1.p1)
- diabetes - Diabetes at enrollment (phv00426881.v1.p1)
- heart_failure - Heart failure at enrollment (phv00426882.v1.p1)
- myocardial_infarction - Myocardial infarction at enrollment (phv00426883.v1.p1)
- valvular_heart_disease - Valvular heart disease at enrollment (phv00426884.v1.p1)
Medications (1)
- hypertension - Hypertension at enrollment (phv00426880.v1.p1)
Race and Ethnicity (2)
- ethnicity - Ethnicity of participant (phv00426877.v1.p1)
- race - Race of participant (phv00426876.v1.p1)
Other (18)
- af_status - AF status (phv00426872.v1.p1)
- ANALYTE_TYPE - Analyte Type (phv00426890.v1.p1)
- BODY_SITE - Body site where sample was collected (phv00426889.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00426867.v1.p1)
- EF_ever_50 - EF ever <50% (phv00426887.v1.p1)
- Funding_Source - Project funding source (phv00426893.v1.p1)
- IS_TUMOR - Tumor status (phv00426891.v1.p1)
- LA_size_echo - LA size by echo (closest to enrollment) (phv00426885.v1.p1)
- LVEF_echo - LVEF by echo (closest to enrollment) (phv00426886.v1.p1)
- SAMPLE_ID - Sample ID (phv00426888.v1.p1)
- SAMPLE_ID - Sample ID (phv00426870.v1.p1)
- SEQUENCING_CENTER - Name of the center which conducted sequencing (phv00426892.v1.p1)
- Study_Name - TOPMed-assigned short study name (1:1 with TOPMed phs number) (phv00426896.v1.p1)
- SUBJECT_ID - De-identified Subject ID (phv00426871.v1.p1)
- SUBJECT_ID - Subject ID (phv00426866.v1.p1)
- SUBJECT_ID - Subject ID (phv00426869.v1.p1)
- TOPMed_Phase - TOPMed Phase (phv00426894.v1.p1)
- TOPMed_Project - TOPMed Project that funded sequencing (phv00426895.v1.p1)